X-37: X-37, LLC : Appoints David Gluckman, M.D., to Board of Directors

(marketscreener.com) X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that David Gluckman, M.D., has joined the company's Board of Directors. Dr. Gluckman is Vice Chairman of Investment Banking and Global Head of Lazard's Healthcare Group. He has been with Lazard since 1998, providing strategic and financial advice to...https://www.marketscreener.com/news/latest/X-37-LLC-Appoints-David-Gluckman-M-D-to-Board-of-Directors--31652403/?utm_medium=RSS&utm_content=20201030